These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9096367)

  • 1. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.
    Bronte V; Carroll MW; Goletz TJ; Wang M; Overwijk WW; Marincola F; Rosenberg SA; Moss B; Restifo NP
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3183-8. PubMed ID: 9096367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.
    Bronte V; Tsung K; Rao JB; Chen PW; Wang M; Rosenberg SA; Restifo NP
    J Immunol; 1995 May; 154(10):5282-92. PubMed ID: 7730632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigens.
    Overwijk WW; Surman DR; Tsung K; Restifo NP
    Methods; 1997 Jun; 12(2):117-23. PubMed ID: 9184376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model.
    Kaufman HL; Rao JB; Irvine KR; Bronte V; Rosenberg SA; Restifo NP
    J Immunother; 1999 Nov; 22(6):489-96. PubMed ID: 10570747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.
    Chamberlain RS; Carroll MW; Bronte V; Hwu P; Warren S; Yang JC; Nishimura M; Moss B; Rosenberg SA; Restifo NP
    Cancer Res; 1996 Jun; 56(12):2832-6. PubMed ID: 8665522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity.
    Kaufman HL; Flanagan K; Lee CS; Perretta DJ; Horig H
    Vaccine; 2002 Mar; 20(13-14):1862-9. PubMed ID: 11906776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen.
    Carroll MW; Overwijk WW; Surman DR; Tsung K; Moss B; Restifo NP
    J Natl Cancer Inst; 1998 Dec; 90(24):1881-7. PubMed ID: 9862625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
    Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
    J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.
    Carroll MW; Overwijk WW; Chamberlain RS; Rosenberg SA; Moss B; Restifo NP
    Vaccine; 1997 Mar; 15(4):387-94. PubMed ID: 9141209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
    Rao JB; Chamberlain RS; Bronte V; Carroll MW; Irvine KR; Moss B; Rosenberg SA; Restifo NP
    J Immunol; 1996 May; 156(9):3357-65. PubMed ID: 8617961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen.
    Medina E; Paglia P; Rohde M; Colombo MP; Guzmán CA
    Eur J Immunol; 2000 Mar; 30(3):768-77. PubMed ID: 10741391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant vaccinia virus expressing cytokine GM-CSF as tumor vaccine.
    Chatterjee SK; Qin H; Manna S; Tripathi PK
    Anticancer Res; 1999; 19(4B):2869-73. PubMed ID: 10652566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A consideration of previously uncharacterized fowl poxvirus unidirectional and bidirectional late promoters for inclusion in homologous recombinant vaccines.
    Srinivasan V; Schnitzlein WM; Tripathy DN
    Avian Dis; 2003; 47(2):286-95. PubMed ID: 12887188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model.
    Espenschied J; Lamont J; Longmate J; Pendas S; Wang Z; Diamond DJ; Ellenhorn JD
    J Immunol; 2003 Mar; 170(6):3401-7. PubMed ID: 12626601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
    Paglia P; Chiodoni C; Rodolfo M; Colombo MP
    J Exp Med; 1996 Jan; 183(1):317-22. PubMed ID: 8551239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
    Flanagan K; Glover RT; Hörig H; Yang W; Kaufman HL
    Vaccine; 2004 Jul; 22(21-22):2894-903. PubMed ID: 15246626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.
    Wang M; Bronte V; Chen PW; Gritz L; Panicali D; Rosenberg SA; Restifo NP
    J Immunol; 1995 May; 154(9):4685-92. PubMed ID: 7722321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12.
    Mackova J; Kutinova L; Hainz P; Krystofova J; Sroller V; Otahal P; Gabriel P; Nemeckova S
    Int J Oncol; 2004 Jun; 24(6):1581-8. PubMed ID: 15138603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen.
    Wang M; Chen PW; Bronte V; Rosenberg SA; Restifo NP
    J Immunother Emphasis Tumor Immunol; 1995 Oct; 18(3):139-46. PubMed ID: 8770769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines.
    Hodge JW; Schlom J
    Cancer Res; 1999 Oct; 59(20):5106-11. PubMed ID: 10537283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.